Hydrochloric Acid → 1-(4-(6-(3-Aminopiperidin-1-yl)pyridin-3-ylamino)-6-(3,5-dichloro-4-hydroxyphenyl)quinolin-3-yl)propan-1-one
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C:10]2[CH:11]=[C:12]3[C:17](=[CH:18][CH:19]=2)[N:16]=[CH:15][C:14]([C:20](=[O:23])[CH2:21][CH3:22])=[C:13]3[NH:24][C:25]2[CH:26]=[CH:27][C:28]([N:31]3[CH2:36][CH2:35][CH2:34][CH:33]([NH:37]C(=O)OC(C)(C)C)[CH2:32]3)=[N:29][CH:30]=2)[CH:5]=[C:6]([Cl:9])[C:7]=1[OH:8].Cl>ClCCl.C(OCC)C>[NH2:37][CH:33]1[CH2:34][CH2:35][CH2:36][N:31]([C:28]2[N:29]=[CH:30][C:25]([NH:24][C:13]3[C:12]4[C:17](=[CH:18][CH:19]=[C:10]([C:4]5[CH:3]=[C:2]([Cl:1])[C:7]([OH:8])=[C:6]([Cl:9])[CH:5]=5)[CH:11]=4)[N:16]=[CH:15][C:14]=3[C:20](=[O:23])[CH2:21][CH3:22])=[CH:26][CH:27]=2)[CH2:32]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
tert-butyl 1-(5-(6-(3,5-dichloro-4-hydroxyphenyl)-3-propionylquinolin-4-ylamino)pyridin-2-yl)piperidin-3-ylcarbamate (35 mg, 0.055 mmol) was dissolved in dichloromethane (5 mL). To this solution was added a 2.0 M HCl solution in diethyl ether (2 mL) the mixture was stirred for 16 h at room temperature where a precipitate formed. The precipitate was filtered off, washed with dichloromethane (10 mL), dried under vacuum to obtain the desired product as the HCl salt (12 mg, 33%) as a yellow solid: 1H NMR (500 MHz, MeOD) δ 9.29 (s, 1H), 8.24 (m, 2H), 8.04 (m, 2H), 7.81 (d, J=8.3 Hz, 1H), 7.31 (s, 2H), 7.25 (d, J=8.9 Hz, 1H), 4.53 (s, 1H), 4.06 (d, J=13.3 Hz, 1H), 3.39 (m, 2H), 3.24 (q, J=14.1, 7.0 Hz, 2H), 2.22 (m, 1H), 1.98 (m, 1H), 1.74 (m, 2H), 1.25 (t, J=6.9 Hz, 3H); ESI MS m/z 536, [C28H27Cl2N5O2+H]+; HPLC 98.9% (AUC), tR=10.33 min.
Workup
- customformed
- filtrationThe precipitate was filtered off
- washwashed with dichloromethane (10 mL)
- customdried under vacuum
Sources & evidence
- ORD record
- ord-8f75f97a9a9a4892be7f85d2abbdcea1
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…